Jump to content


Photo

NextGen Cost


  • Please log in to reply
7 replies to this topic

#1 gooddoc

gooddoc

    Newbie

  • Members
  • Pip
  • 1 posts
  • Your EMR:none
  • Degree / Title:MD
  • Why Interested:Physician

Posted 18 March 2006 - 02:30 PM

I am a member of a multi-specialty group 100+ physicians. We were quoted a price on NextGen's EHR of $1,000 per month per physician. Is this typical for large groups requesting an integrated system? I appreciate any info you can offer.

#2 EMRGURU

EMRGURU

    Newbie

  • Members
  • Pip
  • 1 posts
  • Your EMR:NextGen
  • Time Using EMR:5 years
  • Consultant:My self
  • Degree / Title:CEO
  • Why Interested:I am an independent consultant

Posted 19 March 2006 - 04:33 PM

QUOTE (gooddoc @ Mar 18 2006, 01:30 PM)
I am a member of a multi-specialty group 100+ physicians. We were quoted a price on NextGen's EHR of $1,000 per month per physician. Is this typical for large groups requesting an integrated system? I appreciate any info you can offer.


NextGen does not normally quote prices that way unless you are looking to lease the software from an ASP. We you looking at purchasing NextGen or leasing it?

#3 techguy

techguy

    Member

  • Members
  • PipPip
  • 22 posts
  • Your EMR:Medicat

Posted 23 March 2006 - 06:17 PM

It looks like the EMR Price Matrix I often use doesn't show a monthly charge for Nextgen. They are at the bottom of the list if you want to see the pricing they have. It sounds like the pricing you got was for an ASP model.

#4 Robert Gleeman

Robert Gleeman

    Member

  • Members
  • PipPip
  • 89 posts
  • Consultant:Independent
  • Why Interested:EMR Journalist

Posted 13 April 2006 - 07:52 AM

QUOTE (techguy @ Mar 23 2006, 04:17 PM)
It looks like the EMR Price Matrix I often use doesn't show a monthly charge for Nextgen.  They are at the bottom of the list if you want to see the pricing they have.  It sounds like the pricing you got was for an ASP model.


A popular sales tactic is to quote what a leasing company would charge. The leasing company pays the EMR vendor upfront, then charges the doctor lease payments by the month to repay the loan.

This means that no refund, cancellation, or switch to a new EMR is possible, and that doctor now has no real exit strategy. He is stuck with those lease payments no matter how the EMR works out for him.

Why risk the removal or the EMR vendor's incentive to perform by paying in advance for services not yet rendered? Many, if not most, EMR vendors have a monthly subscription option which does not involve a leasing company. It's a good way to keep your options open. See the link quoted above for vendors who sell EMR services on a monthly, or even a per-new-patient, subscription basis.

#5 pancake

pancake

    Advanced Member

  • Members
  • PipPipPip
  • 151 posts

Posted 26 February 2009 - 02:49 PM

HORSHAM, Pa.-- (BUSINESS WIRE) -- NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of healthcare information systems and connectivity solutions for physicians and medical groups, today announced its enthusiastic support for the economic stimulus bill that - among other initiatives - allocates a minimum of $19 billion in funding to accelerate the adoption of health care information technology.

“We applaud the foresight and commitment of our nation’s leaders,” says Patrick Cline, president of NextGen Healthcare. “Increased adoption of information technology will help address many of the problems plaguing the healthcare industry, and we look forward to playing a role in this new effort aimed at reducing healthcare costs and enhancing patient care.”

The Economic Reinvestment and Recovery Act earmarks $2-3 billion for construction of HIT infrastructure and about $17 billion in Medicare/Medicaid incentives payable to physicians and hospitals that can demonstrate “meaningful” use of certified HIT, particularly electronic health records (EHR). Practices and organizations that do so by 2011 are eligible to receive a $15,000 bonus from the government, with decreasing amounts available during the ensuing three years. To provide more information on this new legislation, NextGen Healthcare has unveiled an Internet-based resource - www.nextgen.com/stimulus - designed to help providers understand the impact of the legislation on their organization and begin to formulate next steps.

Long recognized as a leader in HIT and standards development through its work with organizations such as the Certification Commission for Health Information Technology (CCHIT), NextGen Healthcare offers EHR systems that are positioned to meet all standards that the government will be endorsing as part of this new law.

Featuring specialty specific content and powerful disease management capabilities, NextGen Healthcare also provides organizations with a health outcomes data solution needed to meet the government’s proposed stimulus incentive (pay-for-performance) requirements. In addition to working with private medical practices, NextGen Healthcare exhibits a breadth of experience with Federally Qualified Health Centers (FQHC’s) Community Health Clinics (CHC’s) and Indian Health organizations.

Finally, NextGen Healthcare offers a leading health information exchange technology (NextGen Community Health Solution or “NextGen CHS”) designed to provide interoperability between disparate medical practices, hospitals and other stakeholders within a community.

“Because we have been at the forefront of HIT development for many years, we will not need to invest time getting up-to-speed,” noted Cline. “We are prepared, and are ready to help healthcare organizations make a smooth transition from paper to electronic processes.”

About NextGen Healthcare

NextGen Healthcare Information Systems, Inc. a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII), provides integrated electronic health record and practice management systems, connectivity solutions, and billing services for hospitals and ambulatory practices of all sizes and specialties. For more information about NextGen, please visit www.nextgen.com and www.qsii.com.

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue and net income), are forward-looking statements within the meaning of these laws and involve a number of risks and uncertainties. Management believes that these forward-looking statements are reasonable and are based on reasonable assumptions and forecasts, however, undue reliance should not be placed on such statements that speak only as of the date hereof. Moreover, these forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: volume and timing of systems sales and installations; length of sales cycles and installation process; the possibility that the products will not achieve market acceptance; seasonal patterns of sales and customer buying behavior; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; uncertainties concerning threatened, pending and new litigation against the Company including related professional services fees; uncertainties concerning the amount and timing of professional fees incurred by the Company generally; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; general economic conditions; and the risk factors detailed from time to time in Quality Systems' periodic reports and registration statements filed with the Securities and Exchange Commission. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of the fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.


For NextGen Healthcare Information Systems, Inc.

Brian Parrish, 770-576-2544

bparrish@dodgecommunications.com


#6 hula girl

hula girl

    Advanced Member

  • Members
  • PipPipPip
  • 148 posts

Posted 24 March 2009 - 11:52 AM

HORSHAM, Pa.--(BUSINESS WIRE)--NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of ambulatory healthcare information systems and connectivity solutions, today announced that MEDNAX, Inc., a national physician group practice, is expanding its use of NextGen Healthcare’s enterprise software solutions to include the NextGen EPM (Enterprise Practice Management) product. Pediatrix Medical Group, now a part of MEDNAX, has been utilizing the NextGen EHR (Electronic Health Records) product for its office-based practices since 2001.

Physicians practicing as part of MEDNAX specialize in neonatology, maternal-fetal medicine, pediatric cardiology, pediatric intensive care, pediatric and OBGYN hospitalist services and anesthesiology. The combined strengths of the NextGen EPM and NextGen EHR products promote increased efficiency by allowing providers to share information nationwide through a uniform platform. NextGen EPM allows healthcare organizations with multiple locations to centralize appointments, billing, collections and other business processes. The NextGen EHR product provides access to specialty-specific and disease management templates, charts and lab results, e-prescribing with pharmacies, health maintenance alerts, medication recalls, and more.

“We’ve had great success utilizing the NextGen EHR product during the past eight years and are confident that the NextGen EPM system will provide similar efficiencies,” said Bob Bryant, senior vice president, chief information officer, for MEDNAX. “By utilizing both products, we’re aiming to improve clinical and administrative data sharing for our providers. Our organization includes providers across the country, so it’s very important for them to be able to exchange information regarding a patient’s health record or to access billing information for services rendered.”

About NextGen Healthcare

NextGen Healthcare Information Systems, Inc. a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII), provides integrated electronic health record and practice management systems, connectivity solutions, and billing services for hospitals and ambulatory practices of all sizes and specialties. For more information about NextGen, please visit www.nextgen.com and www.qsii.com.

About MEDNAX, Inc.

MEDNAX, Inc., is a national medical group that comprises the nation's leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was founded in 1979 and now includes neonatal physicians who provide services at more than 250 neonatal intensive care units, who collaborate with affiliated maternal-fetal medicine, pediatric cardiology and pediatric intensivist physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation's largest provider of newborn hearing screens. MEDNAX, through its affiliated professional corporations, employs more than 1,200 physicians in 32 states and Puerto Rico. Additional information is available at www.mednax.com.

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue and net income), are forward-looking statements within the meaning of these laws and involve a number of risks and uncertainties. Management believes that these forward-looking statements are reasonable and are based on reasonable assumptions and forecasts, however, undue reliance should not be placed on such statements that speak only as of the date hereof. Moreover, these forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: volume and timing of systems sales and installations; length of sales cycles and installation process; the possibility that the products will not achieve market acceptance; seasonal patterns of sales and customer buying behavior; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; uncertainties concerning threatened, pending and new litigation against the Company including related professional services fees; uncertainties concerning the amount and timing of professional fees incurred by the Company generally; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; general economic conditions; and the risk factors detailed from time to time in Quality Systems' periodic reports and registration statements filed with the Securities and Exchange Commission. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of the fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.


Contacts
NextGen Healthcare Information Systems, Inc.
Brian Parrish, 770-576-2544
bparrish@dodgecommunications.com



#7 Dorvillius

Dorvillius

    Advanced Member

  • Members
  • PipPipPip
  • 140 posts

Posted 26 March 2011 - 05:15 PM

Another couple of resources to determine issues relating to EHR selection are:

EHR Selection: EMR Comparison
EHR Selection: EMR Consultant

I found them both to be very helpful. :thumbsup:

#8 DrD

DrD

    Member

  • Members
  • PipPip
  • 56 posts
  • Gender:Male
  • Your EMR:-
  • Time Using EMR:-
  • Manufacturer:-
  • Consultant:-
  • Degree / Title:CIO
  • Why Interested:Like to Keep Up with Press Releases
  • Location:Europe

Posted 08 May 2011 - 10:04 AM

Seems like the price of most EHRs has declined over the past year, with some of them actually being free, but most of them being in the neighborhood of hundreds of dollars per doctor per month, instead of a thousand dollars per doctor per month.

Clearly a step in the right direction...




0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users